Accurate measurement of tumor mutation burden in liquid biopsy (bTMB) using a 500 gene panelTingting Jiang, Sven Bilke, Shu Zhang et al.|Annals of Oncology|2018Cited by 5
Molecular profiling of ctDNA from NCI-MATCH patients enrolled for treatment with mTOR1/2 inhibitor sapanisertib (arm M) and the Hedgehog pathway inhibitor vismodegib (arm T).Jennifer S. LoCoco, Chris Karlovich, Lisa M. McShane et al.|Journal of Clinical Oncology|2023Cited by 2
Blood-based assessment of patients with mismatch repair-deficient tumors enrolled in NCI-MATCH Arm Z1D (nivolumab).Chris Karlovich, P. Mickey Williams, Jennifer L. Silhavy et al.|Journal of Clinical Oncology|2023Cited by 1
Evaluation of microsatellite instability testing through cell-free DNA sequencingShu Zhang, Kristina M. Kruglyak, Jennifer S. LoCoco et al.|Annals of Oncology|2019Cited by 1
Molecular profiling of plasma from matched NCI-MATCH gynecological cancers.Amanda Peach, Chris Karlovich, Bao T. Le et al.|Journal of Clinical Oncology|2024Cited by 1